• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Public Health . National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance

tetano

Editor, Senior Moderator
BMC Public Health


. 2022 Jun 9;22(1):1151.
doi: 10.1186/s12889-022-13433-0.
National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance


Thierry Rigoine de Fougerolles[SUP] 1 [/SUP], Oliver Damm[SUP] 2 [/SUP], Filippo Ansaldi[SUP] 3 [/SUP], Maria Chironna[SUP] 4 [/SUP], Pascal Crépey[SUP] 5 [/SUP], Simon de Lusignan[SUP] 6 7 [/SUP], Ian Gray[SUP] 8 [/SUP], José Maria Guillen[SUP] 9 [/SUP], George Kassianos[SUP] 7 [/SUP], Anne Mosnier[SUP] 10 [/SUP], Raul Ortiz de Lejarazu[SUP] 11 [/SUP], Elena Pariani[SUP] 12 [/SUP], Joan Puig-Barbera[SUP] 13 [/SUP], Jörg Schelling[SUP] 14 [/SUP], Francesca Trippi[SUP] 15 [/SUP], Philippe Vanhems[SUP] 16 17 [/SUP], Klaus Wahle[SUP] 18 [/SUP], John Watkins[SUP] 19 [/SUP], Anvar Rasuli[SUP] 20 [/SUP], Olivier Vitoux[SUP] 1 [/SUP], Hélène Bricout[SUP] 21 [/SUP]



Affiliations

Abstract

Background: Influenza surveillance systems vary widely between countries and there is no framework to evaluate national surveillance systems in terms of data generation and dissemination. This study aimed to develop and test a comparative framework for European influenza surveillance.
Methods: Surveillance systems were evaluated qualitatively in five European countries (France, Germany, Italy, Spain, and the United Kingdom) by a panel of influenza experts and researchers from each country. Seven surveillance sub-systems were defined: non-medically attended community surveillance, virological surveillance, community surveillance, outbreak surveillance, primary care surveillance, hospital surveillance, mortality surveillance). These covered a total of 19 comparable outcomes of increasing severity, ranging from non-medically attended cases to deaths, which were evaluated using 5 comparison criteria based on WHO guidance (granularity, timing, representativeness, sampling strategy, communication) to produce a framework to compare the five countries.
Results: France and the United Kingdom showed the widest range of surveillance sub-systems, particularly for hospital surveillance, followed by Germany, Spain, and Italy. In all countries, virological, primary care and hospital surveillance were well developed, but non-medically attended events, influenza cases in the community, outbreaks in closed settings and mortality estimates were not consistently reported or published. The framework also allowed the comparison of variations in data granularity, timing, representativeness, sampling strategy, and communication between countries. For data granularity, breakdown per risk condition were available in France and Spain, but not in the United Kingdom, Germany and Italy. For data communication, there were disparities in the timeliness and accessibility of surveillance data.
Conclusions: This new framework can be used to compare influenza surveillance systems qualitatively between countries to allow the identification of structural differences as well as to evaluate adherence to WHO guidance. The framework may be adapted for other infectious respiratory diseases.

Keywords: Comparison; Europe; Influenza; Qualitative evaluation framework; Surveillance systems.
 
Back
Top Bottom